MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis

Clinical trial NCT02171104 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02171104
Sponsor: Masonic Cancer Center, University of Minnesota
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Mucopolysaccharidosis Disorders Hurler Syndrome Hunter Syndrome Maroteaux Lamy Syndrome Sly Syndrome Alpha-Mannosidosis Fucosidosis Aspartylglucosaminuria Glycoprotein Metabolic Disorders Sphingolipidoses Recessive Leukodystrophies Globoid Cell Leukodystrophy

Start date: 2014-07-10
Primary completion: 2026-01-05
Enrollment: 149

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.